Intragen log record 40:CFR-01.Dr. Leonard Kendall, - Ingen Bio - Senior Director of Applied Biotechnology.

> I have begun longitudinal chemotherapy research on a new experimental recombinant protein: Intragen.

4 views0 comments

Recent Posts

See All


> Cytotoxicity and its effect on lymphocytes is of utmost importance. I must find a way to balance the protein's effects. If I am successful, it will mean no more cancer, no more HIV virus, no more Eb


One Ingen Campus Center Plaza
Salt Lake City, UT 84101



T: 1-800-INGEN-BIO

  • facebook
  • w-tbird

© 2018 IngenBio Corporation. ALL RIGHTS RESERVED

This site was designed with the
website builder. Create your website today.
Start Now